Daisyu Toya

Fukui-ken Saiseikai Hospital — Japan

Medicine · Health Sciences

16h-index934citations39works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Diabetes, Cardiovascular Risks, and Lipoproteins(7), Hepatocellular Carcinoma Treatment and Prognosis(7), Diabetes Treatment and Management(7), Diabetes Management and Research(7), Hepatitis C virus research(6)

Publications39 total

Efficient Prophylactic Management of HBV Reactivation by an Information Technology Encoding System: Results of a 6-year Prospective Cohort Study
Internal Medicine·2020· 6 citedOpen Access
Tripartite collaboration among designated hospitals, administration, and medical associations for the treatment of liver disease of 100% of patients who are positive for hepatitis virus in the hospitals: efforts for referral to hepatologists
Kanzo·2020· 1 citedOpen Access
Treatment patterns and outcomes of unresectable pancreatic cancer patients in real-life practice: a region-wide analysis
Japanese Journal of Clinical Oncology·2018· 38 citedOpen Access
Change in renal tubular function and phosphorus metabolism by switching from previous nucleotide analogues to Tenofovir alafenamide fumarate in treatment of chronic hepatitis B
Kanzo·2018Open Access
The effects of ipragliflozin on the liver-to-spleen attenuation ratio as assessed by computed tomography and on alanine transaminase levels in Japanese patients with type 2 diabetes mellitus
Diabetology International·2017· 34 citedOpen Access
High LDL cholesterol in DAA treatment for chronic hepatitis C -Comparative study between each DAA treatment-
Kanzo·2017· 1 citedOpen Access
Long-Term Patency of Metallic Stents in a Patient with Bile Duct Injury Refractory to Long-Term Catheter Placement Following Right Hepatectomy for Liver Metastasis
Interventional Radiology·2017Open Access
Ipragliflozin lowers small, dense low-density lipoprotein cholesterol levels in Japanese patients with type 2 diabetes mellitus
Journal of Clinical & Translational Endocrinology·2016· 23 citedOpen Access
Chronic hyperglycemia may attenuate the serum-uric-acid-lowering effect of low-dose febuxostat in Japanese patients with type 2 diabetes mellitus
Diabetology International·2016· 1 citedOpen Access
Switching from atorvastatin to rosuvastatin lowers small, dense low-density lipoprotein cholesterol levels in Japanese hypercholesterolemic patients with type 2 diabetes mellitus
Diabetes Research and Clinical Practice·2015· 6 cited
Non-high-density cholesterol level as a predictor of maximum carotid intima-media thickness in Japanese subjects with type 2 diabetes: a comparison with low-density lipoprotein level
Diabetology International·2015· 5 citedOpen Access
Efficacy and Safety of Insulin Glulisine in Intensive Insulin Therapy: Bolus Insulin Adjust Nice Control by apiDRA Study (BANDRA Study)
Journal of Diabetes Mellitus·2015· 1 citedOpen Access
Predictive clinical parameters for the hemoglobin A1c-lowering effect of vildagliptin in Japanese patients with type 2 diabetes
Diabetology International·2014· 1 cited
Automated risk management of HBV reactivation by encoding patients^|^apos; medical records
Kanzo·2014· 3 citedOpen Access
Determinants of the HbA1c-lowering effect of sitagliptin when added to ongoing insulin therapy in Japanese patients with type 2 diabetes
Diabetology International·2013· 2 cited
Fluorodeoxyglucose accumulation in the left atrial appendage of a patient with paroxysmal atrial fibrillation
Journal of Cardiology Cases·2011· 2 citedOpen Access
Obesity may attenuate the HbA1c‐lowering effect of sitagliptin in Japanese type 2 diabetic patients
Journal of Diabetes Investigation·2011· 35 citedOpen Access
Chemoembolization for the Treatment of Large Hepatocellular Carcinoma
Journal of Vascular and Interventional Radiology·2010· 35 cited
Main Bile Duct Stricture Occurring After Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma
CardioVascular and Interventional Radiology·2010· 67 cited
Association of serum glycated albumin to haemoglobin A<sub>1C</sub> ratio with hepatic function tests in patients with chronic liver disease
Annals of Clinical Biochemistry International Journal of Laboratory Medicine·2009· 38 cited
page 1 of 2Next →

Frequent Co-authors

Nobuyoshi Tanaka(25), Yoshiyuki Bando(16), Kazuo Notsumata(15), Shiro Miyayama(11), Hideo Kanehara(11), Osamu Matsui(9), Azusa Hisada(9), Kazuhiro Okafuji(9), Keiko Aoki(7), Takeshi Mitsui(6), Hiroyuki Watanabe(6), Masakiyo Fujisawa(6), Taku Sanada(6), Masashi Yamashiro(5), Yasuyuki Ushiogi(5), Teruyuki Ueda(5), Tetsuya Minami(4), Yoshimoto Nomura(4), Keiichi Taki(3), Chiharu Ito(3)